A deadly viral illness is exploding in West Africa. Researchers are scrambling to figure out why
Reporting for this story was supported by the Pulitzer Center. Irrua, Nigeria, and Kenema, Sierra Leone— Sitting on a bench outside the Irrua Specialist Teaching Hospital (ISTH) in Edo state in southwestern Nigeria in September 2023, Muhammed Luqman Dagana recounted his ordeal earlier in the year with Lassa fever, a deadly hemorrhagic disease of West Africa. At first the 33-year-old wasn’t alarmed—his fever, headache, body aches, and cough were innocuous enough. A doctor at his local clinic gave him antibiotics for typhoid fever and antimalarial drugs. But his symptoms persisted, so he tried anoth...
Source: ScienceNOW - February 22, 2024 Category: Science Source Type: news

Uganda Sees Health Workforce Gains; Increases in Family Planning and Safe Deliveries at End of USAID Project
cbalesFebruary 19, 2024February 19, 2024Between 2017 and 2023, Uganda strengthened its health workforce and systems, improved health services, and championed locally led development in collaboration with IntraHealth ’sRegional Health Integration to Enhance Services in Eastern Uganda (RHITES-E) Activity.Led by IntraHealth in partnership with The AIDS Support Organization (TASO), Communication for Development Foundation Uganda (CDFU), Malaria Consortium, and Medic, the USAID-funded project worked closely with the government at the national and local levels to expand access to high-quality health services. RHITES-E also sup...
Source: IntraHealth International - February 19, 2024 Category: International Medicine & Public Health Authors: cbales Source Type: news

Last of the HIV Vaccine Trials Fails, Scientists Regroup Last of the HIV Vaccine Trials Fails, Scientists Regroup
Vaccinations were stopped after it became clear they would not be effective. " We cannot and will not lose hope that the world will have an effective HIV vaccine, " the International AIDS director said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2023 Category: Consumer Health News Tags: HIV/AIDS Source Type: news

News at a glance: AI rules for Europe, vaccines for Africa, and a union for NIH early-career researchers
HEALTH EQUITY A billion-dollar boost for vaccinemaking in Africa Gavi, the Vaccine Alliance, has committed up to $1 billion to bolster Africa’s ability to sustainably produce its own doses of lifesaving vaccines. Manufacturers based in Africa produce only 1% of the vaccine doses used on the continent. Last week, Gavi announced that with money left over from the COVID-19 Vaccines Global Access Facility—an effort to provide an equitable distribution of COVID-19 vaccines—it would create the African Vaccine Manufacturing Accelerator (AVMA) to focus on preventing 11 priority infectious diseases. As ...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news

Africa: HIV Vaccine Trial in Africa Halted Due to Ineffectiveness
[New Times] The initial attempt in Africa to assess the efficacy of two combined vaccines against HIV has been terminated as researchers determined that the intervention was ineffective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 13, 2023 Category: African Health Tags: Africa HIV-Aids and STDs Health and Medicine Source Type: news

HIV Vaccine Trial in Africa Halted After Disappointing Data HIV Vaccine Trial in Africa Halted After Disappointing Data
A trial of an experimental HIV vaccine stopped early after preliminary data suggested it would not be effective in preventing infection, according to the trial ' s chief investigator.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 9, 2023 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

South Africa: Africa's First HIV Vaccine Trial Fails
[allAfrica] Harare -- An experimental HIV vaccine trial conducted in South Africa, Tanzania, and Uganda was prematurely terminated due to preliminary findings indicating the vaccine would not be successful in preventing infection, Reuters reports. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - December 8, 2023 Category: Infectious Diseases Tags: HIV-Aids and STDs East Africa Health and Medicine South Africa Southern Africa Tanzania Uganda Source Type: news

'End of This Phase': Trial Halts Testing of HIV Vaccine Candidates
(MedPage Today) -- The PrEPVacc trial has stopped administering two investigational HIV vaccines that showed no efficacy in preventing infection, investigators announced on Wednesday during the International Conference on AIDS and STIs in Africa... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - December 7, 2023 Category: Infectious Diseases Source Type: news

HIV vaccine trial in Africa halted after disappointing initial results
African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV riskThefirst trial in Africa of two combination vaccines to prevent HIV has been halted after researchers concluded it was not working.The pre-exposure prophylaxis vaccine (PrEPVacc) was being tested on 1,500 people aged between 18 and 40 in Uganda, Tanzania and South Africa.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 7, 2023 Category: Science Authors: Samuel Okiror in Kampala Tags: Global development Aids and HIV Society Global health Uganda Tanzania South Africa Vaccines and immunisation World news Medical research Science Source Type: news

The Updated COVID-19 Shot Works on the Newest Variants
Every COVID-19 vaccine is a step behind the virus. In the time it takes companies to make the shot, SARS-CoV-2 is already busy mutating into different versions that can evade the immune response produced by it. But even though the latest vaccine targets XBB.1.5, a variant no longer dominant in the U.S., it seems to be doing a decent job at warding off some of the emerging variants. In a study published on the preprint server bioRxiv, scientists led by Dr. David Ho, director of the Aaron Diamond AIDS Research Center at Columbia University, report that the vaccine can generate strong antibodies that can neutralize not jus...
Source: TIME: Health - December 7, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Mpox-Associated Hospitalization Among JYNNEOS Vaccinated Persons Mpox-Associated Hospitalization Among JYNNEOS Vaccinated Persons
Even a single dose of JYNNEOS vaccine reduced mpox-associated hospitalization rates compared with those who were unvaccinated, according to this CDC study,Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 17, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

Uganda: Museveni Challenges Scientists On HIV/Aids Vaccine
[Nile Post] President Yoweri Kaguta Museveni has challenged local scientists to fast-track the development of the HIV/AIDS vaccine. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - October 28, 2023 Category: Infectious Diseases Tags: HIV-Aids and STDs East Africa Governance Health and Medicine Uganda Source Type: news

Epidemiologic and Clinical Features of Mpox in Adults > 50 Years Epidemiologic and Clinical Features of Mpox in Adults > 50 Years
While childhood smallpox vaccination may provide some protection against mpox, adults at risk for mpox, regardless of smallpox vaccination status, should receive the mpox vaccine.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - October 27, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

At UNGA, Civil Society Must Mobilize Global Solidarity for Universal Health Coverage
By , Founding Executive Director, African Center for Global Health and Social TransformationcbalesSeptember 12, 2023September 12, 2023 12:00 PMAs world leaders prepare for the United Nations General Assembly (UNGA) in New York, it ’s important for those of us in civil society to prepare ourselves ideologically to engage, especially for pushing leaders to make commitments during the UN High-Level Meeting on Universal Health Coverage (UHC) on September 21. The theme for this important gathering is Universal health coverage: expanding our ambition for health and well-being in a post-COVID world.We all have a right to...
Source: IntraHealth International - September 12, 2023 Category: International Medicine & Public Health Authors: cbales Source Type: news

An Mpox Cluster Affecting Persons Previously Vaccinated An Mpox Cluster Affecting Persons Previously Vaccinated
In this unusual cluster of mpox cases, a large number of cases had been vaccinated with mpox vaccine.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 4, 2023 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news